# Nanostring Technologies, Inc.

- Location (FDA's records): Seattle, WA
- FDA decisions: 2 (2013–2014): 2 510(k) clearances
- Names in FDA's records: Nanostring Technologies, Inc. (1); Nanostring Technologies (1)
- Product codes: NYI (2)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Agendia BV: 2 (https://510kreport.com/company/agendia)

## Its most-cited devices
- K130010: Prosigna (TM) Breast Cancer Prognostic Gene Signature Assay (2013), cited by 1

## Recent decisions
- K141771: Prosigna Breast Cancer Prognostic Gene Signature Assay (Nov 7, 2014)
- K130010: Prosigna (TM) Breast Cancer Prognostic Gene Signature Assay (Sep 6, 2013)

Source page: https://510kreport.com/company/nanostring-technologies